Bristol Myers Squibb stock: Bank of America cuts target for Bristol Myers Squibb stock to USD 66.00
Published on 10/16/2026 at 17:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and trading date
- Bank of America cut its Bristol Myers Squibb target to USD 66.00 on October 9, 2026.
- Third-quarter results are scheduled for October 29, 2026 at 8:00 a.m. ET.
- Bristol Myers Squibb stock costs EUR 54.03 at Lang & Schwarz on October 16, 2026 at 5:31 p.m. CEST.
- Bristol Myers Squibb had a P/E ratio of 13.38 and a USD 124.1 billion market capitalization on October 16, 2026.
Bank of America cut its target for Bristol Myers Squibb from USD 71.00 to USD 66.00 on October 9, 2026, while keeping a Hold rating, according to MarketBeat. The target was 8.63 percent above the NYSE price of USD 60.76 at 11:32 a.m. ET on October 16, 2026. Bristol Myers Squibb stock was trading at EUR 54.03 at Lang & Schwarz on October 16, 2026 at 5:31 p.m. CEST.
The target cut sets a marker
The move from USD 71.00 to USD 66.00 gives the latest analyst view a more cautious frame. MarketBeat reported that Bank of America maintained its Hold rating with the lower target on October 9, 2026. The target remains above the NYSE price cited on October 16, 2026, but the comparison uses the company stock's US listing and USD values rather than the euro quotation.
Price position within the yearly range
Bristol Myers Squibb traded between USD 60.52 and USD 61.43 on the NYSE on October 16, 2026, with 2,063,711 shares changing hands against an average volume of 11,560,498 shares. Its 52-week range was USD 42.52 to USD 68.64, placing the NYSE price 11.48 percent below the high and 42.90 percent above the low. The euro quotation therefore sits well inside the yearly US-dollar range rather than at either boundary.
Valuation and the next results
The company had a USD 124.1 billion market capitalization and a P/E ratio of 13.38 on October 16, 2026. Bristol Myers Squibb is scheduled to report third-quarter 2026 results on October 29, 2026, with the conference call due at 8:00 a.m. ET, according to Bristol Myers Squibb.
Comparison with peers
Bristol Myers Squibb (NYSE, USD): P/E 13.38, market capitalization USD 124.1 billion.
AbbVie (NYSE, USD): daily change 0.70 percent, P/E 80.38, market capitalization USD 504.3 billion.
Pfizer (NYSE, USD): daily change 0.39 percent, P/E 39.05, market capitalization USD 168.5 billion.
Market position at the close
The stock's USD valuation sits below both named peers on the reported P/E measure, while its market value is also below AbbVie's and Pfizer's. The next scheduled results date gives investors a defined calendar point for the company's earnings picture.
Bristol Myers Squibb stock was trading at EUR 54.03 at Lang & Schwarz on October 16, 2026 at 5:31 p.m. CEST.
The further course of trading is shown by the continuously updated real-time quote of Bristol Myers Squibb stock.
Key stock details
- Company: Bristol-Myers Squibb Company
- ISIN: US1101221083
- Ticker: BMY
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 16, 2026, 5:31 p.m. CEST): EUR 54.03
- Market capitalization: USD 124.1 billion (as of October 16, 2026)
- 52-week range: USD 42.52-68.64 (as of October 16, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - General
Market context: Market report S&P 500.
